Via Twitter word is that the "unexpected adverse reaction in a participant" is a UK female hospitalized with transverse myelitis that includes loss of use of her hands & feet.
Transverse myelitisan is an inflammatory syndrome that affects the spinal cord & is often sparked by viral infections.
Just awful news for the lady and her family, I hope she recovers her full health.
Tweet yesterday from Sarah-Jane Marsh (Director Testing, NHS Test & Trace)
Can I please offer my heartfelt apologies to anyone who cannot get a COVID test at present. All of our testing sites have capacity, which is why they don’t look overcrowded, its our laboratory processing that is the critical pinch-point. We are doing all we can to expand quickly.
Avacta can make these challenges go away, any new tests that require lab processing will not solve the problem as lab processing is stretched to its limit.
For any PI's new to AIM you will experience regular share volatility, especially with this stock now. The MM's will do whatever they can to unlock shares for institutional buying orders. Be very careful with stop losses, MM's will test the SP south to unlock them (185, 180, 175,170). You head to work happy with your holding and come home to find it's gone because your stop loss was enabled.
If you are comfortable with your investment but feel uncomfortable not having a stop loss don't set it too high, it could be unlocked and the SP is back up again before you know it.
Do Your Own Research.
GLA
HoldforGold
Any pharma that rushes a vaccine through runs a huge risk of opening themselves up to lawsuits if the vaccine has some long term impact which takes time to reveal itself. There is a reason vaccines take so long to bring to market. Thought I'd read somewhere that in the US they'd approached US Govt to underwrite the risk of this happening in exchange for pushing them through quickly.
Great point, I'd agree HardtoHandle.
Think RM was saying we've got some great global investors now paying special interest to us and the money is there for us if we need it because you pharma boys don't want to pony up.
COPD came back good.
The dataset is strong
He's speaking to multi governments
He's speaking to multiple agencies
He's had offers of funding
He's speaking to all the right people
I'm a lot more comfortable about SNG this evening than yesterday evening.
IMHO the timing is perfect, the uncertainty of heading into the Autumn/Winter with Covid numbers on the rise again means RM has the best deck of cards to play and from the subtle grin earlier he's enjoying the game.
Whatever happens next the news should be very good for Covid Patients and Shareholders.
GLA
Great summary johnht thanks.
Holders need to have a little more patience. The Covid-19 pressure cooker that we saw in the Spring and early Summer is building again. Sadly Covid Infections and deaths are on the rise again in Europe. I have a friend who works in a London NHS ICU and Covid patient numbers are on the rise there. Staff are very concerned about the Autumn/Winter and other seasonal flu's adding to the misery.
The above will combine and the pressure to give EUA will be huge. Thankfully, Synairgen have good data to more than justify its approval.
Just seen another article reported an hour ago on this mornings RNS, forms part of the FT's Coronavirus latest section:
Synairgen trial shows drug-enhancing lung response in some patients
https://www.ft.com/content/0abf7a95-174b-3aa6-9568-cf16e5b613ee
What bats can teach us about developing immunity to Covid-19 | Free to read
https://www.ft.com/content/743ce7a0-60eb-482d-b1f4-d4de11182fa9
Wishing everyone at ODX the best, I have a small holding here but mostly in other stocks Inc one named in this post.
'I have heard from 1 VERY credible reference in the UK Pharma sector that he's absolutely full of sh11t. He's the laughing stock of the UK testing companies. '
This little story reminds me of a meeting that took place in 2000 between Netflix CEO Reed Hastings and Blockbuster CEO John Antioco. At the time, Netflix were desperately short of cash as the post dotcom bubble had started to burst.
But the Blockbuster execs thought Netflix was a joke, an ant to stamp on. That day, Netflix could have been sold to Blockbuster Video for $50m but weren't.
Today, the Netflix MCap is $227 Billion
Blockbuster Video has gone the way of Woolworths, Maplin, Nokia, HMV, Enron, Borders, PanAm, Polaroid, Toys r Us, Kodak to name a few.
My point is, never underestimate market change, especially where companies do not themselves innovate at a time when newer, more powerful and innovative technologies and approaches to business are emerging.
An never underestimate a CEO who has the foresight to recognise an opportunity and make a change that might temporarily be unpopular.
GLA DYOR
Avacta launches a new product which has independent verification that its 500x better than a existing good product in the market.
The Avacta PhD boffins are biotech rock stars, affimers are gonna rule the world.
Scientists from around the globe will be screaming 'get me affimers, we're looking like cave men with our existing tech.'
GLA
An Immune Protein Could Prevent Severe COVID-19—if It Is Given at the Right Time, Synairgen referenced at the end of the article.
https://www.scientificamerican.com/article/an-immune-protein-could-prevent-severe-covid-19-if-it-is-given-at-the-right-time1/